Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

September 15, 2009 (Vol. 29, No. 16)

In Defense of Virtual Development Models

Strategy Allows Advances To Be Driven by Scientific Data Rather than Firm's Prospects

  • Concepts like asset management, capital efficiency, value creation, and virtual development seem to dominate the planning and execution of drug development programs today. Given the challenging financial environment, containing costs and maximizing the value of each development dollar is critical to assuring that the industry continues to pursue promising ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.